Literature DB >> 10362049

Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease.

J A Smith1, P Redman, M A Woodhead.   

Abstract

The objective of this report was to document the pattern of initial antibiotic prescribing in acute exacerbations of chronic obstructive pulmonary disease (COPD) in a hospital setting. All episodes of acute exacerbation of COPD, as diagnosed by the admitting doctor, in one hospital in the period January to May 1996, were identified. Case notes were reviewed retrospectively. Cases of radiographic pneumonia, bronchiectasis and incorrectly coded admissions were excluded. Symptoms, microbial cultures and initial antibiotic therapies were recorded. One hundred and fifty-nine patient episodes were identified; 40 were excluded yielding a sample of 119. Nineteen case notes were unavailable leaving a sample of 100 (84%) episodes. Eighty were treated with antibiotics on admission; amoxycillin was the most frequently prescribed, in 46 (58%) episodes. Of the antibiotic treated group, 42 (53%) patients were given dual therapy, most commonly a macrolide antibiotic with either amoxycillin or a cephalosporin. Intravenous treatment was used in 22 (28%) cases. The duration of intravenous treatment was >48 h in 12 (15%) cases. A total of 76 sputum samples were analysed from 55 patient episodes: 34 (45%) were culture positive. In 15 (27%) patient episodes, antibiotic therapy was changed or instituted on the basis of culture results. These data suggest that antibiotic treatment is not optimal, with overuse of antibiotics, especially intravenous and dual therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362049     DOI: 10.1034/j.1399-3003.1999.13d23.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

Review 1.  Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease.

Authors:  A J White; S Gompertz; R A Stockley
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

2.  EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit.

Authors:  Mir S Adil; M Amer Khan; M Nematullah Khan; Ihtisham Sultan; M Aamer Khan; S Amir Ali; Afroze Farooqui
Journal:  J Clin Diagn Res       Date:  2015-11-01

3.  Pneumonic vs nonpneumonic acute exacerbations of COPD.

Authors:  David Lieberman; Devora Lieberman; Yevgenia Gelfer; Raiesa Varshavsky; Bella Dvoskin; Maija Leinonen; Maureen G Friedman
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

Review 4.  Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.

Authors:  Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.